Mr. Barry Bratcher serves as the Acting CEO of KBio and brings more than 30 years of experience developing and running cGMP processes for expressing and purifying recombinant proteins and plants. He oversaw the 2014-2016 execution of more than 60 consecutive cGMP runs of the zMapp anti-Ebola monoclonal antibody.
KBio Inc is a wholly owned subsidiary of KBio Holdings Limited, a BAT Group company.
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
CookieLawInfoConsent | 1 year | CookieYes sets this cookie to record the default button state of the corresponding category and the status of CCPA. It works only in coordination with the primary cookie. |
elementor | never | The website's WordPress theme uses this cookie. It allows the website owner to implement or change the website's content in real-time. |
PHPSESSID | session | This cookie is native to PHP applications. The cookie stores and identifies a user's unique session ID to manage user sessions on the website. The cookie is a session cookie and will be deleted when all the browser windows are closed. |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
Cookie | Duration | Description |
---|---|---|
_pk_id.#### | 1 year 1 month | Used to store a few details about the user such as the unique visitor ID. |
_pk_ses.#### | 1 hour | Short lived cookies used to temporarily store data for the visit. |